GlobalData analysis suggests that the research and development of DMTs and non-m...
A team of researchers from Uppsala University and KTH Royal Institute of Technol...
At IDWeek 2024 in Los Angeles, California, recent updates on mpox (formerly know...
Zai Lab and argenx have announced receipt of approval from the National Medical ...
The US Food and Drug Administration (FDA) has awarded the second breakthrough th...
BostonGene is a winner in four categories in the 2024 Pharmaceutical Technology ...
Dizal has submitted sunvozertinib’s new drug application (NDA) to the US Food an...
Experts in the neuropsychiatry drug development space say targeting the right pa...
Maximizing the potential AI/data-driven model of drug discovery requires the tec...
Santen Pharmaceutical and Arctic Vision have signed a commercial collaboration a...
In Canada pharmaceutical industry, there were two private equity deals announced...
The seemingly inexorable rise in global obesity is being reflected in the sales ...
Leqembi is approved for Alzheimer’s patients in multiple territories, but questi...
Aurinia has announced a 45% workforce reduction to bolster sales of the lupus dr...
LakeShore Biopharma has commenced the submission of its biologics license applic...
A Phase III trial with the companies’ monoclonal antibody in patients with chron...
